232 related articles for article (PubMed ID: 30005860)
1. Therapy of scleroderma renal crisis: State of the art.
Zanatta E; Polito P; Favaro M; Larosa M; Marson P; Cozzi F; Doria A
Autoimmun Rev; 2018 Sep; 17(9):882-889. PubMed ID: 30005860
[TBL] [Abstract][Full Text] [Related]
2. Management of scleroderma renal crisis.
Nagaraja V
Curr Opin Rheumatol; 2019 May; 31(3):223-230. PubMed ID: 30870219
[TBL] [Abstract][Full Text] [Related]
3. Scleroderma renal crisis.
Mouthon L; Bussone G; Berezné A; Noël LH; Guillevin L
J Rheumatol; 2014 Jun; 41(6):1040-8. PubMed ID: 24833760
[TBL] [Abstract][Full Text] [Related]
4. Studying the Role of C5-Inhibition Therapy in Scleroderma Renal Crisis-Induced Thrombotic Microangiopathy - A Review of Literature.
Farrukh L; Steen VD; Shapiro L; Mehta S
Semin Arthritis Rheum; 2023 Dec; 63():152256. PubMed ID: 37689027
[TBL] [Abstract][Full Text] [Related]
5. Scleroderma renal crisis.
Bose N; Chiesa-Vottero A; Chatterjee S
Semin Arthritis Rheum; 2015 Jun; 44(6):687-94. PubMed ID: 25613774
[TBL] [Abstract][Full Text] [Related]
6. ACE inhibitors in SSc patients display a risk factor for scleroderma renal crisis-a EUSTAR analysis.
Bütikofer L; Varisco PA; Distler O; Kowal-Bielecka O; Allanore Y; Riemekasten G; Villiger PM; Adler S;
Arthritis Res Ther; 2020 Mar; 22(1):59. PubMed ID: 32209135
[TBL] [Abstract][Full Text] [Related]
7. Scleroderma renal crisis is still a life-threatening syndrome.
Stratta P; Besso L; Ferrero S; Canavese C; Hollo S; Ottone S; Sandri L; Thea A; Mazzucco G
Ren Fail; 1996 Jul; 18(4):567-74. PubMed ID: 8875681
[TBL] [Abstract][Full Text] [Related]
8. Recent Developments in the Classification, Evaluation, Pathophysiology, and Management of Scleroderma Renal Crisis.
Ghossein C; Varga J; Fenves AZ
Curr Rheumatol Rep; 2016 Jan; 18(1):5. PubMed ID: 26711696
[TBL] [Abstract][Full Text] [Related]
9. Scleroderma renal crisis as an initial presentation of systemic sclerosis: a case report and review of the literature.
Logee KM; Lakshminarayanan S
Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S171-4. PubMed ID: 25797912
[TBL] [Abstract][Full Text] [Related]
10. Management review of scleroderma renal crisis: An update with practical pointers.
Foocharoen C; Tonsawan P; Pongkulkiat P; Anutrakulchai S; Mahakkanukrauh A; Suwannaroj S
Mod Rheumatol; 2023 Jan; 33(1):12-20. PubMed ID: 35349704
[TBL] [Abstract][Full Text] [Related]
11. Case-control study of corticosteroids and other drugs that either precipitate or protect from the development of scleroderma renal crisis.
Steen VD; Medsger TA
Arthritis Rheum; 1998 Sep; 41(9):1613-9. PubMed ID: 9751093
[TBL] [Abstract][Full Text] [Related]
12. Scleroderma renal crisis during intravenous cyclophosphamide pulse therapy for complicated interstitial lung disease was successfully treated with angiotensin converting enzyme inhibitor and plasma exchange.
Nagamura N; Kin S
Nagoya J Med Sci; 2016 Aug; 78(3):329-34. PubMed ID: 27578917
[TBL] [Abstract][Full Text] [Related]
13. Scleroderma renal crisis and renal involvement in systemic sclerosis.
Woodworth TG; Suliman YA; Li W; Furst DE; Clements P
Nat Rev Nephrol; 2016 Nov; 12(11):678-691. PubMed ID: 27641135
[TBL] [Abstract][Full Text] [Related]
14. Scleroderma Renal Crisis Complicated with Thrombotic Microangiopathy Triggered by Influenza B Virus Infection.
Shimizu T; Iwamoto N; Okamoto M; Endo Y; Tsuji S; Takatani A; Igawa T; Umeda M; Fukui S; Sumiyoshi R; Kitamura M; Koga T; Kawashiri SY; Ichinose K; Tamai M; Nakamura H; Origuchi T; Nishino T; Kawakami A
Intern Med; 2019 Feb; 58(3):441-445. PubMed ID: 30146597
[TBL] [Abstract][Full Text] [Related]
15. Renal Disease and Systemic Sclerosis: an Update on Scleroderma Renal Crisis.
Cole A; Ong VH; Denton CP
Clin Rev Allergy Immunol; 2023 Jun; 64(3):378-391. PubMed ID: 35648373
[TBL] [Abstract][Full Text] [Related]
16. Scleroderma renal crisis: Case reports and update on critical issues.
Zanatta E; Codullo V; Allanore Y
Eur J Rheumatol; 2021 Jul; 8(3):162-167. PubMed ID: 33226326
[TBL] [Abstract][Full Text] [Related]
17. Prognosis of scleroderma renal crisis: a long-term observational study.
Cozzi F; Marson P; Cardarelli S; Favaro M; Tison T; Tonello M; Pigatto E; De Silvestro G; Punzi L; Doria A
Nephrol Dial Transplant; 2012 Dec; 27(12):4398-403. PubMed ID: 22859795
[TBL] [Abstract][Full Text] [Related]
18. Scleroderma renal crisis: a retrospective multicentre study on 91 patients and 427 controls.
Guillevin L; Bérezné A; Seror R; Teixeira L; Pourrat J; Mahr A; Hachulla E; Agard C; Cabane J; Vanhille P; Harle JR; Deleveaux I; Mouthon L
Rheumatology (Oxford); 2012 Mar; 51(3):460-7. PubMed ID: 22087012
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin-converting enzyme inhibitors prior to scleroderma renal crisis in systemic sclerosis: A systematic review and meta-analysis.
Xiong A; Cao Y; Xiang Q; Song Z; Zhang Y; Zhou S; Qiang Y; Chen H; Hu Z; Cui H; Luo J; Wang Y; Yang Y; Yang M; Shuai S
J Clin Pharm Ther; 2022 Jun; 47(6):722-731. PubMed ID: 35233779
[TBL] [Abstract][Full Text] [Related]
20. The scleroderma kidney: progress in risk factors, therapy, and prevention.
Bussone G; Bérezné A; Pestre V; Guillevin L; Mouthon L
Curr Rheumatol Rep; 2011 Feb; 13(1):37-43. PubMed ID: 21061100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
